Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nazila Assasi
Cost-Utility Analysis of Infliximab and Adalimumab for Refractory Ulcerative Colitis
Cost Effectiveness and Resource Allocation
Health Policy
Related publications
Cost-Minimization Analysis of Infliximab Versus Adalimumab in the Treatment of Crohn’s Disease and Ulcerative Colitis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Utility Analysis of 1-Year Treatment With Adalimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland
European Journal of Clinical Pharmacology
Medicine
Pharmacology
Long-Term Efficacy of Infliximab for Refractory Ulcerative Colitis: Results From a Single Center Experience
BMC Gastroenterology
Medicine
Gastroenterology
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
New England Journal of Medicine
Medicine
Cost-Effectiveness of Infliximab for the Treatment of Acute Exacerbations of Ulcerative Colitis in the Netherlands
Biologics in Therapy
Comparative Efficacy and Safety of Golimumab, Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis: A Bayesian Indirect Treatment Comparison Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Adalimumab for Ulcerative Colitis: Results of a Brazilian Multicenter Observational Study
Arquivos de Gastroenterologia
Gastroenterology
Utility of Surveillance Colonoscopy in Ulcerative Colitis.
Gut
Gastroenterology
Letter: Dose Optimising Infliximab in Acute Severe Ulcerative Colitis
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
